- Home
- LPSN vs OSTX Comparison
LPSN vs OSTX Comparison
Compare LPSN & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- OSTX
- Stock Information
- Founded
- LPSN 1995
- OSTX 2018
- Country
- LPSN United States
- OSTX United States
- Employees
- LPSN N/A
- OSTX N/A
- Industry
- LPSN EDP Services
- OSTX
- Sector
- LPSN Technology
- OSTX
- Exchange
- LPSN Nasdaq
- OSTX NYSE
- Market Cap
- LPSN 93.0M
- OSTX 86.5M
- IPO Year
- LPSN 2000
- OSTX 2024
- Fundamental
- Price
- LPSN $0.85
- OSTX $3.81
- Analyst Decision
- LPSN Hold
- OSTX Strong Buy
- Analyst Count
- LPSN 6
- OSTX 2
- Target Price
- LPSN $1.18
- OSTX $14.50
- AVG Volume (30 Days)
- LPSN 1.7M
- OSTX 110.3K
- Earning Date
- LPSN 11-07-2024
- OSTX 02-15-2025
- Dividend Yield
- LPSN N/A
- OSTX N/A
- EPS Growth
- LPSN N/A
- OSTX N/A
- EPS
- LPSN N/A
- OSTX N/A
- Revenue
- LPSN $334,736,000.00
- OSTX N/A
- Revenue This Year
- LPSN N/A
- OSTX N/A
- Revenue Next Year
- LPSN N/A
- OSTX $9,900.00
- P/E Ratio
- LPSN N/A
- OSTX N/A
- Revenue Growth
- LPSN N/A
- OSTX N/A
- 52 Week Low
- LPSN $0.45
- OSTX $1.58
- 52 Week High
- LPSN $3.98
- OSTX $6.48
- Technical
- Relative Strength Index (RSI)
- LPSN 44.08
- OSTX N/A
- Support Level
- LPSN $0.77
- OSTX N/A
- Resistance Level
- LPSN $0.92
- OSTX N/A
- Average True Range (ATR)
- LPSN 0.06
- OSTX 0.00
- MACD
- LPSN 0.00
- OSTX 0.00
- Stochastic Oscillator
- LPSN 38.45
- OSTX 0.00
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.